+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Non-Invasive Prenatal Testing (NIPT) Market, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis

  • PDF Icon

    Report

  • 135 Pages
  • March 2022
  • Region: Global
  • Renub Research
  • ID: 5562675
Global Non-Invasive Prenatal Testing (NIPT) Market is expected to reach US$ 6.65 Billion in 2027. Non-invasive prenatal testing (NIPT) is a prenatal screening that uses a blood sample from a pregnant woman to detect fetal abnormalities. Furthermore, by detecting DNA fragments in the mother's blood, the test is primarily used to diagnose genetic diseases such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13), and Turner syndrome. Surprisingly, the procedure eliminates the need for several risky and invasive procedures, including chorionic villus sampling (CVS), which can be done after nine weeks of pregnancy.



During the COVID-19 pandemic, close contact with the FDA resulted in Minimal Impact:


The COVID-19 epidemic had little impact on the market for non-invasive prenatal diagnostics. Several manufacturing companies were in regular contact with the U.S. Food and Drug Administration to keep them aware of any supply chain disruptions. In addition, many research studies were done to estimate the commercial impact of COVID-19.

In-vitro diagnostics manufacturers and clinical testing laboratories team with research organizations to determine the effect of SARS-CoV-2 infection on pregnancy and congenital disabilities in newborns, as well as the need for non-invasive prenatal testing during the COVID pandemic, according to a SeraCare report. However, the lack of established outcomes has cast doubt on the demand for these tests amidst the pandemic. Nevertheless, as per our analysis, the Global Non-Invasive Prenatal Testing (NIPT) Market was US$ 2.85 Billion in 2021.

Worldwide Non-Invasive Prenatal Testing (NIPT) Market Size is expected to grow at a CAGR of 15.2% during 2021-2027:


The rising frequency of chromosomal abnormalities, combined with increased product utilization in new applications, has driven organic revenue growth over the years. Furthermore, the market expansion is expected to be fuelled by innovations in existing tests in advanced functionality, improved chemistry, and bioinformatics analysis. One of the market's main driving forces is the improvement of payment policies for normal and low-risk pregnancies. Natera announced in December 2020 that its non-invasive prenatal testing (NIPT) would be covered by the most extensive U.S. health plan, Aetna, for all pregnancies.

Cell-Free DNA-Based NIPT Market Is Gauged to Generate the Highest Market Share:


In 2021 and during the forecast years, the cell-free DNA-based NIPT market is expected to have the highest market share. Cell-free DNA is increasingly being used to forecast the likelihood of genetic disorders in prenatal care through various genetic tests. Several research studies are now underway to improve the utilization of the tests available through this segment. Nonetheless, ultrasound detection is used with the NIPT test based on cell-free DNA. Furthermore, the ultrasound detection test serves as a foundation for subsequent testing of the baby to discover anomalies. Recent technological developments and 3D-4D imaging have increased the test's real-time monitoring, safety, and efficiency, driving the segment's growth.

NGSS Technology Remains to Be Dominant in All Aspects:


By technology, our analysis studies the markets for ELISA Kits, Next Generation Sequencing Systems, and Microarray Analysis. According to our findings, next-generation sequencing systems (NGSS) dominate the market and hold a significant proportion. Furthermore, the NGSS technology outperforms all other technologies in efficiency, availability, penetration, and technology. As a result, NGSS has become widely used in this field. However, several end users have reported difficulty interpreting results when using NGSS technology.

Over the forecast period, the Low-Risk Pregnancy Testing Market is expected to multiply:


As per our analysis, because of the increased uptake of these tests in high-risk situations in patients aged 35 and above, the market for non-invasive prenatal testing for high and average-risk pregnancies held the most significant share. The dominance of the high and average-risk segments is also due to favorable payer reimbursement and increased awareness regarding the prevention of chromosomal defects such as Down syndrome. The low-risk pregnancy testing market, on the other hand, is expected to rise rapidly over the projected period. Furthermore, government support, such as budget allocation for average-risk pregnancies, is predicted to positively influence the growth of the Low-Risk Pregnancy Testing Market.

Diagnostic Laboratories Holds Lion's Share:


Diagnostic laboratories are the primary end-users of non-invasive tests, so diagnostic laboratories dominate the market. It is predicted to increase at the fastest rate. Compared to hospitals, diagnostic laboratories are equipped with cutting-edge equipment that allows for safe and successful prenatal testing.

Furthermore, the most significant market share is due to well-drafted NIPT laboratory standards in developed regions and a substantial volume of NIPT tests performed in diagnostic laboratories. Moreover, some facilities outsource testing services to diagnostic laboratories, resulting in the segment's expansion.

Regional Insights for Non-Invasive Prenatal Testing (NIPT) Market:


Although the United States lacks national consensus policies on NIPT adoption; yet, it is extensively implemented across the country, resulting in North America's dominance. Furthermore, the recent inclusion of NIPT in major insurance companies' coverage plans is expected to boost the market growth in the United States.

Similarly, the Chancery Division, High Court of Justice, Patents Court of the United Kingdom has ruled that Ariosa's Harmony cell-free, DNA-based NIPT infringes on an Illumina European patent, ensuring the validity of patent claims. Such initiatives are fueling the region's revenue growth.

Key Companies:


Companies developing NIPT solutions operate in a highly competitive commercial environment worldwide. Major players are increasing their test repertoire to differentiate themselves and solidify their market position. Companies also focus on pitching new products and innovating to maintain and expand their market share.

Furthermore, corporations are producing items that meet worldwide needs while also increasing the use of existing products. Eurofins Scientific, F. Hoffman-La Roche, Illumina, Natera, Inc., PerkinElmer Inc., Quest Diagnostics, Thermo Fisher Scientific, and Agilent Technologies are significant competitors in the global non-invasive prenatal testing market.

The publisher's latest report Non-Invasive Prenatal Testing (NIPT) Market, Global Forecast By Method (Ultrasound Detection, Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Others), Technology (ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits), Next Generation Sequencing Systems, Microarray Analysis), Risk Type ( High & Average Risk, Low Risk), End User (Specialty Clinics, Hospitals, Diagnostic Centers), Region (North America, Europe, Asia, Rest of the World (RoW)), Companies (Eurofins Scientific, F. Hoffman-La Roche, Illumina, Natera, Inc., PerkinElmer Inc., Quest Diagnostics, Thermo Fisher Scientific, and Agilent Technologies) provides a detailed analysis of Non-Invasive Prenatal Testing (NIPT) Industry.

Method - Market has been covered from 4 viewpoints:


1. Ultrasound Detection
2. Biochemical Screening Tests
3. Cell-free DNA in Maternal Plasma Tests
4. Others

Technology - Market has been covered from 3 viewpoints:


1. ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits)
2. Next Generation Sequencing Systems
3. Microarray Analysis

Risk Type - Market has been covered from 2 viewpoints:


1. High & Average Risk
2. Low Risk

End User - Market has been covered from 3 viewpoints:


1. Specialty Clinics
2. Hospitals
3. Diagnostic Centers

Region - Market has been covered from 4 viewpoints:


1. North America
2. Europe
3. Asia
4. Rest of the World

Company Insights:


  • Overview
  • Recent Development & Strategies
  • Financial Insights

CompaniesCovered:


1. Eurofins Scientific
2. F. Hoffman-La Roche
3. Illumina
4. Natera, Inc.
5. PerkinElmer Inc.
6. Quest Diagnostics
7. Thermo Fisher Scientific
8. Agilent Technologies
Frequently Asked Questions about the Global Non-Invasive Prenatal Testing Market

What is the estimated value of the Global Non-Invasive Prenatal Testing Market?

The Global Non-Invasive Prenatal Testing Market was estimated to be valued at $2.85 Billion in 2021.

What is the growth rate of the Global Non-Invasive Prenatal Testing Market?

The growth rate of the Global Non-Invasive Prenatal Testing Market is 15.2%, with an estimated value of $6.65 Billion by 2027.

What is the forecasted size of the Global Non-Invasive Prenatal Testing Market?

The Global Non-Invasive Prenatal Testing Market is estimated to be worth $6.65 Billion by 2027.

Who are the key companies in the Global Non-Invasive Prenatal Testing Market?

Key companies in the Global Non-Invasive Prenatal Testing Market include Eurofins Scientific, F. Hoffman, La Roche, Illumina, Natera, Inc., PerkinElmer Inc., Quest Diagnostics and Agilent Technologies.

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Non-Invasive Prenatal Testing (NIPT) Market
6. Market Share - Global Non-Invasive Prenatal Testing (NIPT) Market
6.1 By Method
6.2 By Technology
6.3 By Risk Type
6.4 By End User
6.5 By Region
7. Method - Global Non-Invasive Prenatal Testing (NIPT) Market
7.1 Ultrasound Detection
7.2 Biochemical Screening Tests
7.3 Cell-free DNA in Maternal Plasma Tests
7.4 Others
8. Technology - Global Non-Invasive Prenatal Testing (NIPT) Market
8.1 ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits)
8.2 Next Generation Sequencing Systems
8.3 Microarray Analysis
9. Risk Type - Global Non-Invasive Prenatal Testing (NIPT) Market
9.1 High & Average Risk
9.2 Low Risk
10. End User - Global Non-Invasive Prenatal Testing (NIPT) Market
10.1 Specialty Clinics
10.2 Hospitals
10.3 Diagnostic Centers
11. Region - Global Non-Invasive Prenatal Testing (NIPT) Market
11.1 North America
11.2 Europe
11.3 Asia
11.4 Rest of the World (ROW)
12. Porters Five Forces
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13. Company Analysis
13.1 Eurofins Scientific
13.1.1 Overview
13.1.2 Recent Development & Strategies
13.1.3 Financial Insights
13.2 F. Hoffman-La Roche
13.2.1 Overview
13.2.2 Recent Development & Strategies
13.2.3 Financial Insights
13.3 Illumina
13.3.1 Overvie
13.3.2 Recent Development & Strategies
13.3.3 Financial Insights
13.4 Natera, Inc.
13.4.1 Overview
13.4.2 Recent Development & Strategies
13.4.3 Financial Insights
13.5 PerkinElmer Inc.
13.5.1 Overview
13.5.2 Recent Development & Strategies
13.5.3 Financial Insights
13.6 Quest Diagnostics
13.6.1 Overview
13.6.2 Recent Development & Strategies
13.6.3 Financial Insights
13.7 Thermo Fisher Scientific
13.7.1 Overview
13.7.2 Recent Development & Strategies
13.7.3 Financial Insights
13.8 Agilent Technologies
13.8.1 Overview
13.8.2 Recent Development & Strategies
13.8.3 Financial Insights
List Of Figures:
Figure 01: Global - Non-Invasive Prenatal Testing (NIPT) Market (Billion US$), 2018 - 2021
Figure 02: Global - Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Billion US$), 2022 - 2027
Figure 03: Method - Ultrasound Detection Market (Million US$), 2018 - 2021
Figure 04: Method - Forecast for Ultrasound Detection Market (Million US$), 2022 - 2027
Figure 05: Method - Biochemical Screening Tests Market (Million US$), 2018 - 2021
Figure 06: Method - Forecast for Biochemical Screening Tests Market (Million US$), 2022 - 2027
Figure 07: Method - Cell-free DNA in Maternal Plasma Tests Market (Million US$), 2018 - 2021
Figure 08: Method - Forecast for Cell-free DNA in Maternal Plasma Tests Market (Million US$), 2022 - 2027
Figure 09: Method - Others Market (Million US$), 2018 - 2021
Figure 10: Method - Forecast for Others Market (Million US$), 2022 - 2027
Figure 11: Technology - ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits) Market (Million US$), 2018 - 2021
Figure 12: Technology - Forecast for ELISA Kits (Enzyme-Linked Immunosorbent Assay Kits) Market (Million US$), 2022 - 2027
Figure 13: Technology - Next Generation Sequencing Systems Market (Billion US$), 2018 - 2021
Figure 14: Technology - Forecast for Next Generation Sequencing Systems Market (Billion US$), 2022 - 2027
Figure 15: Technology - Microarray Analysis Market (Million US$), 2018 - 2021
Figure 16: Technology - Forecast for Microarray Analysis Market (Million US$), 2022 - 2027
Figure 17: Risk Type - High & Average Risk Market (Billion US$), 2018 - 2021
Figure 18: Risk Type - Forecast for High & Average Risk Market (Billion US$), 2022 - 2027
Figure 19: Risk Type - Low Risk Market (Million US$), 2018 - 2021
Figure 20: Risk Type - Forecast for Low Risk Market (Million US$), 2022 - 2027
Figure 21: End-User - Specialty Clinics Market (Million US$), 2018 - 2021
Figure 22: End-User - Forecast for Specialty Clinics Market (Million US$), 2022 - 2027
Figure 23: End-User - Hospitals Market (Million US$), 2018 - 2021
Figure 24: End-User - Forecast for Hospitals Market (Million US$), 2022 - 2027
Figure 25: End-User - Diagnostic Centers Market (Billion US$), 2018 - 2021
Figure 26: End-User - Forecast for Diagnostic Centers Market (Billion US$), 2022 - 2027
Figure 27: North America - Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 - 2021
Figure 28: North America - Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 - 2027
Figure 29: Europe - Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 - 2021
Figure 30: Europe - Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 - 2027
Figure 31: Asia - Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 - 2021
Figure 32: Asia - Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 - 2027
Figure 33: Rest of the World (RoW) - Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 - 2021
Figure 34: Rest of the World (RoW) - Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 - 2027
Figure 35: Eurofins Scientific - Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2018 - 2021
Figure 36: Eurofins Scientific - Forecast for Non-Invasive Prenatal Testing (NIPT) Market (Million US$), 2022 - 2027
Figure 37: F. Hoffman-La Roche - Global Revenue (Billion US$), 2018 - 2021
Figure 38: F. Hoffman-La Roche - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 39: Illumina - Global Revenue (Billion US$), 2018 - 2021
Figure 40: Illumina - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 41: Natera, Inc. - Global Revenue (Billion US$), 2018 - 2021
Figure 42: Natera, Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 43: PerkinElmer Inc. - Global Revenue (Billion US$), 2018 - 2021
Figure 44: PerkinElmer Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 45: Quest Diagnostics - Global Revenue (Million US$), 2018 - 2021
Figure 46: Quest Diagnostics - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 47: Thermo Fisher Scientific - Global Revenue (Billion US$), 2018 - 2021
Figure 48: Thermo Fisher Scientific - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure 49: Agilent Technologies - Global Revenue (Billion US$), 2018 - 2021
Figure 50: Agilent Technologies - Forecast for Global Revenue (Billion US$), 2022 - 2027
List Of Tables:
Table 01: Global - Non-Invasive Prenatal Testing (NIPT) Market Share by Method (Percent), 2018 - 2021
Table 02: Global - Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by Method (Percent), 2022 - 2027
Table 03: Global - Non-Invasive Prenatal Testing (NIPT) Market Share by Technology (Percent), 2018 - 2021
Table 04: Global - Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by Technology (Percent), 2022 - 2027
Table 05: Global - Non-Invasive Prenatal Testing (NIPT) Market Share by Risk Type (Percent), 2018 - 2021
Table 06: Global - Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by Risk Type (Percent), 2022 - 2027
Table 07: Global - Non-Invasive Prenatal Testing (NIPT) Market Share by End-User (Percent), 2018 - 2021
Table 08: Global - Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by End-User (Percent), 2022 - 2027
Table 09: Global - Non-Invasive Prenatal Testing (NIPT) Market Share by Region (Percent), 2018 - 2021
Table 10: Global - Forecast for Non-Invasive Prenatal Testing (NIPT) Market Share by Region (Percent), 2022 - 2027

Companies Mentioned

  • Eurofins Scientific
  • F. Hoffman-La Roche
  • Illumina
  • Natera, Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific
  • Agilent Technologies

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...